Friday, July 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “GeneDesign, Inc.”

3 pharma patents match "GeneDesign, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 3 pharmaceutical patents matching "GeneDesign, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3 results for “GeneDesign, Inc.” · 30,257 patents in full index Clear search

  1. US 11479769

    Technique for treating cancer using structurally-reinforced S-TuD

    GeneDesign, Inc. · Granted Oct 25, 2022 · Expires Oct 20, 2042

    granted
  2. US 11268098

    Non-aggregating immunostimulatory oligonucleotides

    GeneDesign, Inc. · Granted Mar 8, 2022 · Expires Mar 3, 2042

    granted
  3. US 10844376

    Structurally-enhanced miRNA inhibitor S-TuD

    GeneDesign, Inc. · Granted Nov 24, 2020 · Expires Nov 19, 2040

    granted